Discussion about this post

User's avatar
Neural Foundry's avatar

ServiceNow Ventures backing Hyro is a very strategic move - it signals NOW's broader ambition beyond traditional ITSM into healthcare workflow automation. Your point about the digital front door still attracting capital is spot on. What's particuarly interesting is Hyro's focus on healthcare-native AI agents (scheduling, prescriptions, patient routing) vs generic conversational AI. The $45M raise with Bon Secours Mercy Health as an investor + customer shows the model is resonating with health systems. David, do you see AI agent platforms like Hyro eventually integrating directly into EHR workflows (Epic, Cerner) as embedded capabilities, or will they remain standalone orchestration layers? The challenge I've seen is that standalone tools create yet another integration point, but EHR vendors move too slowly on innovation. ServiceNow's platform DNA could be the bridge here if they can nail the interoperability piece.

Expand full comment
Rainbow Roxy's avatar

Your commentary about the AMA needing to deliver operational steps is so on point. How do you envision their governance frameworks addressing medical liability?

Expand full comment

No posts